Essential Pharma closes two deals with UK-based Rosemont
With the divestments of UK oral liquid products, Essential Pharma expects to streamline its portfolio and advance its…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Nov 21
With the divestments of UK oral liquid products, Essential Pharma expects to streamline its portfolio and advance its…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
25 Nov 21
J&J’s single-shot vaccine showed 85% protection against Covid-19 related hospitalisation and death, and across different variants
24 Nov 21
Livtencity is an orally bioavailable anti-CMV compound that works by blocking the activity of the human cytomegalovirus enzyme…
24 Nov 21
The EC marketing authorisation was based on results from the Phase 3 ASCENT study of Trodelvy in people…
23 Nov 21
The new 19,000m2 R&D facility that represents £1bn investment will feature the most advanced robotics, high-throughput screening and…
23 Nov 21
Arrowhead will receive $120m in upfront payment for the Phase 1/2 NASH programme, along with potential milestone payments…
22 Nov 21
Gavreto is a once-daily, oral precision medicine that works by selectively targeting rearranged during transfection (RET) alterations, including…
22 Nov 21
Voxzogo is the first treatment for achondroplasia, which is the most common form of disproportionate short stature, said…
19 Nov 21
Under the agreement, Pfizer will supply 10 million courses of the investigational Covid-19 drug to the US government,…
18 Nov 21
The regulatory approval is supported by data from Phase 3 KEEPsAKE-1 and KEEPsAKE-2 studies, evaluating Skyrizi in psoriatic…